WB result of SLU7 (N-acetyl-Ser2) Recombinant Rabbit mAb
Primary antibody: SLU7 (N-acetyl-Ser2) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: HeLa whole cell lysate 20 µg
Lane 2: Jurkat whole cell lysate 20 µg
Lane 3: K562 whole cell lysate 20 µg
Lane 4: HepG2 whole cell lysate 20 µg
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 68 kDa
Observed MW: 76 kDa
Product Details
Product Details
Product Specification
| Host | Rabbit |
| Antigen | SLU7 (N-acetyl-Ser2) |
| Synonyms | Pre-mRNA-splicing factor SLU7; SLU7 |
| Immunogen | Synthetic Peptide |
| Location | Cytoplasm, Nucleus |
| Accession | O95391 |
| Clone Number | S-3662-17 |
| Antibody Type | Recombinant mAb |
| Isotype | IgG |
| Application | WB |
| Reactivity | Hu |
| Positive Sample | HeLa, Jurkat, K562, HepG2 |
| Purification | Protein A |
| Concentration | 0.5 mg/ml |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300 |
| Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
| application | dilution | species |
| Dot Blot | 1:1000 | |
| WB | 1:1000 | Hu |
Background
SLU7 (N-acetyl-Ser2) protein refers to a specific post-translationally modified form of the SLU7 protein, a highly conserved splicing factor essential for the second catalytic step of pre-mRNA splicing in eukaryotes, where the designation "N-acetyl-Ser2" indicates that the serine residue at the second position of its N-terminus has undergone N-terminal acetylation, a common co-translational modification catalyzed by NatA complexes that often influences protein stability, subcellular localization, or interaction with other components of the spliceosome; while the core function of SLU7 involves stabilizing the active site conformation and facilitating the selection of the 3' splice site during exon ligation, this specific N-terminal acetylation may fine-tune its role within the dynamic spliceosomal machinery, potentially affecting its turnover rate or affinity for partner proteins like PRP18 and PRP22, although detailed functional distinctions solely attributable to this specific acetylation mark compared to the non-acetylated form remain an area of ongoing molecular investigation within the broader context of gene expression regulation.
Picture
Picture
Western Blot
Dot Blot
Dot blot result of SLU7 (N-acetyl-Ser2) Recombinant Rabbit mAb
Lane 1: SLU7 S2ac modified peptide
Lane 2: SLU7 S2 unmodified peptide
Primary antibody: SLU7 (N-acetyl-Ser2) Recombinant Rabbit mAb at 1/1000 dilution
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
